asciminib

CHEBI:CHEBI_749791

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2680280
generic_name
asciminib
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
DRUG FOR FURTHER PROCESSING
listing_expiration_date
20251231
route
ORAL
active_ingredient_strength
20 mg/1
dosage_form
TABLET, FILM COATED
marketing_start_date
20211029
package_marketing_start_date
20240418
labeler_name
Novartis Pharma Stein AG
manufacturer_name
Novartis Pharmaceuticals Corporation
active_ingredient_name
ASCIMINIB HYDROCHLORIDE
product_ndc
17088-0156
spl_id
c51075cd-31e2-450f-9e04-8fce2aa3451c
package_ndc
17088-0156-1
package_description
25000 TABLET, FILM COATED in 1 DRUM (17088-0156-1)
brand_name
SCEMBLIX
brand_name_base
SCEMBLIX
application_number
NDA215358
unii
C5U34S9XFV
spl_set_id
e33001e7-3650-42b1-ae56-cddb5c43aa2b
upc
0300781091205
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class